Medicus Pharma
MDCX
3 hedge funds and large institutions have $3.74M invested in Medicus Pharma in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
12.72% more ownership
Funds ownership: 0% → 12.72% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICP
Interchange Capital Partners
Pittsburgh,
Pennsylvania
|
+$3.7M |
| 2 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$73.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$43.4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ICP
1
Interchange Capital Partners
Pittsburgh,
Pennsylvania
| $3.63M | +$3.7M | +1,457,165 | New |
|
|
PIMG
2
Patriot Investment Management Group
Knoxville,
Tennessee
| $70.7K | +$73.9K | +29,103 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $42K | +$43.4K | +17,100 | New |
|
MDCX Hedge Fund Activity: Q4 2024 in Review
3 of the 7,599 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma (MDCX) for Q4 2024, worth a combined $3.74M.
Buyers outnumbered sellers: 3 funds opened new MDCX positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Interchange Capital Partners, opening a new position worth an estimated $3.7M.
- 3 institutional investors held Medicus Pharma (MDCX) as of Q4 2024, up from 0 in Q3 2024.
- Funds reported $3.74M of Medicus Pharma stock for Q4 2024.
- 3 funds opened new Medicus Pharma positions in Q4 2024 and 0 closed out, a net change of +3 holders.
- The largest Medicus Pharma buyer in Q4 2024 was Interchange Capital Partners, an estimated $3.7M added.
Based on aggregated 13F filings for Q4 2024.